

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle fiber development (GO:0048741) | 8.39971416 |
| 2 | actin filament-based movement (GO:0030048) | 7.85693644 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.29151274 |
| 4 | myotube cell development (GO:0014904) | 7.16728999 |
| 5 | glycogen catabolic process (GO:0005980) | 7.12885397 |
| 6 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.98204610 |
| 7 | plasma membrane repair (GO:0001778) | 6.86848261 |
| 8 | glucan catabolic process (GO:0009251) | 6.67946244 |
| 9 | creatine metabolic process (GO:0006600) | 6.65593019 |
| 10 | skeletal muscle tissue regeneration (GO:0043403) | 6.58403491 |
| 11 | striated muscle atrophy (GO:0014891) | 6.46043050 |
| 12 | sarcomere organization (GO:0045214) | 6.45887196 |
| 13 | purine nucleotide salvage (GO:0032261) | 6.36098092 |
| 14 | cellular polysaccharide catabolic process (GO:0044247) | 6.22275713 |
| 15 | carnitine shuttle (GO:0006853) | 6.15203573 |
| 16 | * striated muscle contraction (GO:0006941) | 6.14618984 |
| 17 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.95233084 |
| 18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.93770309 |
| 19 | polysaccharide catabolic process (GO:0000272) | 5.92957043 |
| 20 | response to muscle activity (GO:0014850) | 5.82885532 |
| 21 | regulation of cell communication by electrical coupling (GO:0010649) | 5.78652932 |
| 22 | myofibril assembly (GO:0030239) | 5.75651154 |
| 23 | response to inactivity (GO:0014854) | 5.70105767 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.68459726 |
| 25 | cytidine deamination (GO:0009972) | 5.64524101 |
| 26 | cytidine metabolic process (GO:0046087) | 5.64524101 |
| 27 | cytidine catabolic process (GO:0006216) | 5.64524101 |
| 28 | muscle atrophy (GO:0014889) | 5.61369086 |
| 29 | cardiac myofibril assembly (GO:0055003) | 5.53179976 |
| 30 | striated muscle adaptation (GO:0014888) | 5.48808642 |
| 31 | IMP metabolic process (GO:0046040) | 5.47803284 |
| 32 | * muscle contraction (GO:0006936) | 5.44573565 |
| 33 | glycogen biosynthetic process (GO:0005978) | 5.31726794 |
| 34 | glucan biosynthetic process (GO:0009250) | 5.31726794 |
| 35 | fatty acid transmembrane transport (GO:1902001) | 5.16313641 |
| 36 | NADH metabolic process (GO:0006734) | 5.12336495 |
| 37 | muscle fiber development (GO:0048747) | 5.00661893 |
| 38 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.89347313 |
| 39 | * muscle system process (GO:0003012) | 4.84596396 |
| 40 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.82324110 |
| 41 | * cardiac muscle contraction (GO:0060048) | 4.71663416 |
| 42 | glycogen metabolic process (GO:0005977) | 4.70600727 |
| 43 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.70070166 |
| 44 | glucan metabolic process (GO:0044042) | 4.61284996 |
| 45 | cellular glucan metabolic process (GO:0006073) | 4.61284996 |
| 46 | actomyosin structure organization (GO:0031032) | 4.56019946 |
| 47 | fructose metabolic process (GO:0006000) | 4.55360256 |
| 48 | carnitine transmembrane transport (GO:1902603) | 4.55197784 |
| 49 | cardiac muscle hypertrophy (GO:0003300) | 4.51587659 |
| 50 | muscle organ morphogenesis (GO:0048644) | 4.51492525 |
| 51 | muscle adaptation (GO:0043500) | 4.45073098 |
| 52 | neuronal action potential propagation (GO:0019227) | 4.41636630 |
| 53 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.39739781 |
| 54 | striated muscle hypertrophy (GO:0014897) | 4.31211361 |
| 55 | IMP biosynthetic process (GO:0006188) | 4.27520597 |
| 56 | 2-oxoglutarate metabolic process (GO:0006103) | 4.25302882 |
| 57 | response to activity (GO:0014823) | 4.17044242 |
| 58 | carnitine transport (GO:0015879) | 4.15898280 |
| 59 | amino-acid betaine transport (GO:0015838) | 4.15898280 |
| 60 | cellular response to dexamethasone stimulus (GO:0071549) | 4.14302731 |
| 61 | negative regulation of muscle hypertrophy (GO:0014741) | 4.11164478 |
| 62 | gluconeogenesis (GO:0006094) | 4.11103926 |
| 63 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.10062381 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.07081136 |
| 65 | muscle cell fate commitment (GO:0042693) | 4.03183362 |
| 66 | cellular carbohydrate catabolic process (GO:0044275) | 4.00224904 |
| 67 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.98398394 |
| 68 | regulation of cofactor metabolic process (GO:0051193) | 3.97974237 |
| 69 | regulation of coenzyme metabolic process (GO:0051196) | 3.97974237 |
| 70 | response to dexamethasone (GO:0071548) | 3.86730376 |
| 71 | muscle hypertrophy (GO:0014896) | 3.84958228 |
| 72 | muscle organ development (GO:0007517) | 3.83971283 |
| 73 | muscle structure development (GO:0061061) | 3.78911212 |
| 74 | muscle cell cellular homeostasis (GO:0046716) | 3.72973123 |
| 75 | regulation of relaxation of muscle (GO:1901077) | 3.71270533 |
| 76 | adult heart development (GO:0007512) | 3.69223880 |
| 77 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.68083531 |
| 78 | hexose biosynthetic process (GO:0019319) | 3.67743951 |
| 79 | striated muscle cell development (GO:0055002) | 3.66301660 |
| 80 | myotube differentiation (GO:0014902) | 3.65207357 |
| 81 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.58251961 |
| 82 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.58251961 |
| 83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.56802320 |
| 84 | negative regulation of muscle contraction (GO:0045932) | 3.56257199 |
| 85 | skeletal muscle tissue development (GO:0007519) | 3.49137185 |
| 86 | ubiquinone biosynthetic process (GO:0006744) | 3.45412146 |
| 87 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.44867172 |
| 88 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.44646947 |
| 89 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.44646947 |
| 90 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.42392250 |
| 91 | muscle hypertrophy in response to stress (GO:0003299) | 3.42392250 |
| 92 | cardiac muscle adaptation (GO:0014887) | 3.42392250 |
| 93 | tricarboxylic acid cycle (GO:0006099) | 3.39760714 |
| 94 | * muscle tissue morphogenesis (GO:0060415) | 3.36112488 |
| 95 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.35824562 |
| 96 | cardiac muscle cell development (GO:0055013) | 3.35117761 |
| 97 | striated muscle tissue development (GO:0014706) | 3.34533271 |
| 98 | cellular polysaccharide metabolic process (GO:0044264) | 3.31709658 |
| 99 | regulation of myoblast differentiation (GO:0045661) | 3.29439538 |
| 100 | relaxation of muscle (GO:0090075) | 3.26357132 |
| 101 | heart process (GO:0003015) | 3.25790693 |
| 102 | heart contraction (GO:0060047) | 3.25790693 |
| 103 | positive regulation of cation channel activity (GO:2001259) | 3.24755728 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 3.24722254 |
| 105 | regulation of sulfur metabolic process (GO:0042762) | 3.24579094 |
| 106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.24389127 |
| 107 | AMP metabolic process (GO:0046033) | 3.24013399 |
| 108 | regulation of the force of heart contraction (GO:0002026) | 3.23433792 |
| 109 | myoblast fusion (GO:0007520) | 3.23134278 |
| 110 | positive regulation of myotube differentiation (GO:0010831) | 3.20599276 |
| 111 | regulation of striated muscle contraction (GO:0006942) | 3.20210933 |
| 112 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.19551685 |
| 113 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.17249100 |
| 114 | neuromuscular junction development (GO:0007528) | 3.14615655 |
| 115 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.14518782 |
| 116 | polysaccharide biosynthetic process (GO:0000271) | 3.12416179 |
| 117 | muscle cell development (GO:0055001) | 3.11544123 |
| 118 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.10635101 |
| 119 | positive regulation of myoblast differentiation (GO:0045663) | 3.06439364 |
| 120 | intracellular lipid transport (GO:0032365) | 3.05620239 |
| 121 | polysaccharide metabolic process (GO:0005976) | 3.05307830 |
| 122 | endoplasmic reticulum organization (GO:0007029) | 3.03435217 |
| 123 | cellular carbohydrate biosynthetic process (GO:0034637) | 2.99733700 |
| 124 | syncytium formation (GO:0006949) | 2.98813436 |
| 125 | muscle filament sliding (GO:0030049) | 12.8522635 |
| 126 | actin-myosin filament sliding (GO:0033275) | 12.8522635 |
| 127 | regulation of skeletal muscle contraction (GO:0014819) | 12.7324171 |
| 128 | skeletal muscle contraction (GO:0003009) | 11.3892928 |
| 129 | skeletal muscle adaptation (GO:0043501) | 10.7956584 |
| 130 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.6827812 |
| 131 | actin-mediated cell contraction (GO:0070252) | 10.5098763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.31659622 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.43380737 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.41962510 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.37616183 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.37402568 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.03005310 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.72182865 |
| 8 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.67895464 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.55649662 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.44143651 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.41184838 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.41120584 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.41120584 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.24882262 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.24821156 |
| 16 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.88253617 |
| 17 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.79444592 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76209000 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76120009 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75888041 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.75562866 |
| 22 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.70906807 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.70382527 |
| 24 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.65588261 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64531224 |
| 26 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.61822154 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.57150813 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.55127649 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52654108 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49605127 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.48004743 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46323700 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44858303 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42857286 |
| 35 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.41620426 |
| 36 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41339931 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38356148 |
| 38 | SA1_27219007_Chip-Seq_Bcells_Human | 1.38319074 |
| 39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.36929406 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33283536 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33277635 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32752859 |
| 43 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.32547715 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30639463 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28827473 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.28042218 |
| 47 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.27588066 |
| 48 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.21540168 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20173096 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19966164 |
| 51 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17275723 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15347261 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14971294 |
| 54 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.14548983 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13320329 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12235986 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11964017 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11964017 |
| 59 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10947702 |
| 60 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09685999 |
| 61 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07921886 |
| 62 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.07752899 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07324566 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06816910 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06777452 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.06696096 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06077304 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05836462 |
| 69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04304530 |
| 70 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03948681 |
| 71 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03848951 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03085176 |
| 73 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.02522373 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01823747 |
| 75 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00970611 |
| 76 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00644895 |
| 77 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99248210 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99195320 |
| 79 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.99033312 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98917767 |
| 81 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97317168 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97081430 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96997394 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96656118 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96288936 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95950557 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95642953 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95056288 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94649772 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94057813 |
| 91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93689623 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93222501 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93191072 |
| 94 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93075815 |
| 95 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92226576 |
| 96 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92152058 |
| 97 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91293531 |
| 98 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91108940 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90742536 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90657358 |
| 101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90209346 |
| 102 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.88345571 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87796769 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87751541 |
| 105 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87070778 |
| 106 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86779399 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86669098 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86655581 |
| 109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86503076 |
| 110 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.85797153 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85383909 |
| 112 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85250620 |
| 113 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84962809 |
| 114 | * P68_20966046_ChIP-Seq_HELA_Human | 0.84568505 |
| 115 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.84237781 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84224019 |
| 117 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.83790361 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.83250805 |
| 119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82596350 |
| 120 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82404408 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82011104 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82011104 |
| 123 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81366354 |
| 124 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81128408 |
| 125 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.80819492 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79762686 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.78826795 |
| 128 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78258710 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.76414692 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76310954 |
| 131 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.74877787 |
| 132 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.73559423 |
| 133 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.72477190 |
| 134 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.71373532 |
| 135 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69828579 |
| 136 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.68910780 |
| 137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.68797770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.38232678 |
| 2 | MP0003646_muscle_fatigue | 6.43077824 |
| 3 | MP0000749_muscle_degeneration | 6.42261697 |
| 4 | MP0000751_myopathy | 5.60138971 |
| 5 | MP0000747_muscle_weakness | 4.58713031 |
| 6 | MP0002106_abnormal_muscle_physiology | 4.30447369 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.04988168 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.89188252 |
| 9 | MP0005451_abnormal_body_composition | 3.70826598 |
| 10 | MP0002269_muscular_atrophy | 3.66553473 |
| 11 | MP0005369_muscle_phenotype | 3.58743064 |
| 12 | MP0004130_abnormal_muscle_cell | 3.41386492 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.39492105 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 3.28160364 |
| 15 | MP0000750_abnormal_muscle_regeneration | 3.22670196 |
| 16 | * MP0005620_abnormal_muscle_contractility | 2.98505202 |
| 17 | MP0004233_abnormal_muscle_weight | 2.71954062 |
| 18 | MP0000733_abnormal_muscle_development | 2.38236146 |
| 19 | MP0002332_abnormal_exercise_endurance | 2.25775469 |
| 20 | MP0002108_abnormal_muscle_morphology | 2.08229539 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.91252334 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.77861806 |
| 23 | MP0005330_cardiomyopathy | 1.75751851 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.44516747 |
| 25 | MP0002971_abnormal_brown_adipose | 1.40518755 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.39326375 |
| 27 | MP0004270_analgesia | 1.37256025 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.26312268 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.16835319 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15778674 |
| 31 | MP0004484_altered_response_of | 1.15042319 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.11957799 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.10115129 |
| 34 | MP0005266_abnormal_metabolism | 1.04706552 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.04128925 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.02006626 |
| 37 | MP0002822_catalepsy | 1.01274711 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.01067877 |
| 39 | MP0000013_abnormal_adipose_tissue | 0.99632568 |
| 40 | MP0004134_abnormal_chest_morphology | 0.97349656 |
| 41 | MP0001661_extended_life_span | 0.96569611 |
| 42 | MP0005275_abnormal_skin_tensile | 0.95097815 |
| 43 | MP0003950_abnormal_plasma_membrane | 0.85169913 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 0.82164475 |
| 45 | MP0001544_abnormal_cardiovascular_syste | 0.78801667 |
| 46 | MP0005385_cardiovascular_system_phenoty | 0.78801667 |
| 47 | MP0009250_abnormal_appendicular_skeleto | 0.76431565 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 0.73296233 |
| 49 | MP0000372_irregular_coat_pigmentation | 0.73220158 |
| 50 | MP0001299_abnormal_eye_distance/ | 0.72619356 |
| 51 | MP0004147_increased_porphyrin_level | 0.72090613 |
| 52 | MP0003828_pulmonary_edema | 0.68422673 |
| 53 | MP0002234_abnormal_pharynx_morphology | 0.68068308 |
| 54 | MP0005334_abnormal_fat_pad | 0.67936058 |
| 55 | MP0008961_abnormal_basal_metabolism | 0.67896312 |
| 56 | MP0004043_abnormal_pH_regulation | 0.66228683 |
| 57 | MP0000762_abnormal_tongue_morphology | 0.65245785 |
| 58 | MP0003137_abnormal_impulse_conducting | 0.63158999 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.62437819 |
| 60 | MP0003879_abnormal_hair_cell | 0.59962565 |
| 61 | MP0005670_abnormal_white_adipose | 0.59647824 |
| 62 | MP0000003_abnormal_adipose_tissue | 0.55884725 |
| 63 | MP0005083_abnormal_biliary_tract | 0.52565731 |
| 64 | MP0002089_abnormal_postnatal_growth/wei | 0.51740144 |
| 65 | MP0010030_abnormal_orbit_morphology | 0.50963755 |
| 66 | MP0001346_abnormal_lacrimal_gland | 0.50719911 |
| 67 | MP0000343_altered_response_to | 0.50452904 |
| 68 | MP0000266_abnormal_heart_morphology | 0.49824984 |
| 69 | MP0002896_abnormal_bone_mineralization | 0.47973951 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47732282 |
| 71 | MP0005452_abnormal_adipose_tissue | 0.47538572 |
| 72 | MP0003959_abnormal_lean_body | 0.46394533 |
| 73 | MP0002127_abnormal_cardiovascular_syste | 0.44761536 |
| 74 | MP0008775_abnormal_heart_ventricle | 0.44617379 |
| 75 | MP0008569_lethality_at_weaning | 0.44597240 |
| 76 | MP0009672_abnormal_birth_weight | 0.42274430 |
| 77 | MP0003045_fibrosis | 0.41643130 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.41389244 |
| 79 | MP0004142_abnormal_muscle_tone | 0.39889913 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.37459175 |
| 81 | MP0001849_ear_inflammation | 0.37416132 |
| 82 | MP0002114_abnormal_axial_skeleton | 0.35240314 |
| 83 | MP0001243_abnormal_dermal_layer | 0.34834529 |
| 84 | MP0005503_abnormal_tendon_morphology | 0.33972215 |
| 85 | MP0002796_impaired_skin_barrier | 0.33315434 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.33121119 |
| 87 | MP0000579_abnormal_nail_morphology | 0.32793196 |
| 88 | MP0009115_abnormal_fat_cell | 0.31005469 |
| 89 | MP0000383_abnormal_hair_follicle | 0.30998483 |
| 90 | MP0003948_abnormal_gas_homeostasis | 0.30461172 |
| 91 | MP0002734_abnormal_mechanical_nocicepti | 0.29226185 |
| 92 | MP0006138_congestive_heart_failure | 0.28233218 |
| 93 | MP0005332_abnormal_amino_acid | 0.27839410 |
| 94 | MP0003195_calcinosis | 0.25773357 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.25248906 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.24661481 |
| 97 | MP0005423_abnormal_somatic_nervous | 0.24369659 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.24355607 |
| 99 | MP0005535_abnormal_body_temperature | 0.24181073 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.23880716 |
| 101 | MP0008770_decreased_survivor_rate | 0.23031422 |
| 102 | MP0004510_myositis | 0.21874086 |
| 103 | MP0005165_increased_susceptibility_to | 0.21635046 |
| 104 | MP0001943_abnormal_respiration | 0.20772350 |
| 105 | MP0001853_heart_inflammation | 0.20748270 |
| 106 | MP0005166_decreased_susceptibility_to | 0.20448747 |
| 107 | MP0005187_abnormal_penis_morphology | 0.19769842 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.19102431 |
| 109 | MP0004858_abnormal_nervous_system | 0.18794843 |
| 110 | MP0002249_abnormal_larynx_morphology | 0.18493373 |
| 111 | MP0002932_abnormal_joint_morphology | 0.18274481 |
| 112 | MP0002128_abnormal_blood_circulation | 0.18135977 |
| 113 | MP0004085_abnormal_heartbeat | 0.17967837 |
| 114 | MP0003567_abnormal_fetal_cardiomyocyte | 0.17081333 |
| 115 | MP0003755_abnormal_palate_morphology | 0.16919043 |
| 116 | MP0002066_abnormal_motor_capabilities/c | 0.16688525 |
| 117 | MP0003385_abnormal_body_wall | 0.16570854 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.14345916 |
| 119 | MP0009840_abnormal_foam_cell | 0.14091435 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.12773830 |
| 121 | MP0008874_decreased_physiological_sensi | 0.12536155 |
| 122 | MP0004197_abnormal_fetal_growth/weight/ | 0.10787056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.65065561 |
| 2 | Nemaline bodies (HP:0003798) | 9.03194259 |
| 3 | Exercise-induced myalgia (HP:0003738) | 9.01155585 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 8.24092493 |
| 5 | Distal arthrogryposis (HP:0005684) | 7.53646583 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 7.38992310 |
| 7 | Myopathic facies (HP:0002058) | 6.97044906 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.93073430 |
| 9 | Round ear (HP:0100830) | 6.51142268 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 6.42073074 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 6.03307651 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.59109029 |
| 13 | Difficulty running (HP:0009046) | 5.55360010 |
| 14 | Myoglobinuria (HP:0002913) | 5.41797648 |
| 15 | Muscle fiber splitting (HP:0003555) | 5.30429786 |
| 16 | Absent phalangeal crease (HP:0006109) | 5.19286353 |
| 17 | Deformed tarsal bones (HP:0008119) | 5.16703197 |
| 18 | Muscle stiffness (HP:0003552) | 4.97680533 |
| 19 | Hyporeflexia of lower limbs (HP:0002600) | 4.77658446 |
| 20 | Rhabdomyolysis (HP:0003201) | 4.57005041 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.54588202 |
| 22 | Increased connective tissue (HP:0009025) | 4.50685397 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 4.35282826 |
| 24 | Myotonia (HP:0002486) | 4.25703311 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 4.01415731 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.87894465 |
| 27 | Malignant hyperthermia (HP:0002047) | 3.59328030 |
| 28 | Rimmed vacuoles (HP:0003805) | 3.54854970 |
| 29 | Neck muscle weakness (HP:0000467) | 3.49029156 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.46237612 |
| 31 | Abnormality of the calcaneus (HP:0008364) | 3.40481451 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.38169353 |
| 33 | Shoulder girdle muscle weakness (HP:0003547) | 3.37376624 |
| 34 | Pelvic girdle muscle weakness (HP:0003749) | 3.37153302 |
| 35 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.25490402 |
| 36 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.25490402 |
| 37 | Frequent falls (HP:0002359) | 3.24943490 |
| 38 | Hyperkalemia (HP:0002153) | 3.17023092 |
| 39 | Areflexia of lower limbs (HP:0002522) | 3.16439092 |
| 40 | Bundle branch block (HP:0011710) | 2.79905643 |
| 41 | Slender build (HP:0001533) | 2.75263031 |
| 42 | Paralysis (HP:0003470) | 2.72313043 |
| 43 | Fatigable weakness (HP:0003473) | 2.58194849 |
| 44 | Abnormality of the neuromuscular junction (HP:0003398) | 2.58194849 |
| 45 | * Abnormality of the left ventricular outflow tract (HP:0011103) | 2.49686954 |
| 46 | * Subaortic stenosis (HP:0001682) | 2.49686954 |
| 47 | EMG: neuropathic changes (HP:0003445) | 2.48916503 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 2.45104974 |
| 49 | Muscular dystrophy (HP:0003560) | 2.40859946 |
| 50 | Dilated cardiomyopathy (HP:0001644) | 2.39723876 |
| 51 | Limb-girdle muscle weakness (HP:0003325) | 2.30831944 |
| 52 | Hypoplastic ischia (HP:0003175) | 2.29992474 |
| 53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27508698 |
| 54 | Nonprogressive disorder (HP:0003680) | 2.23503071 |
| 55 | Generalized muscle weakness (HP:0003324) | 2.20077063 |
| 56 | Proximal amyotrophy (HP:0007126) | 2.16475620 |
| 57 | Metatarsus adductus (HP:0001840) | 2.16454393 |
| 58 | Ulnar deviation of finger (HP:0009465) | 2.15157214 |
| 59 | Spinal rigidity (HP:0003306) | 2.14948772 |
| 60 | Bulbar palsy (HP:0001283) | 2.14582747 |
| 61 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.07135627 |
| 62 | * Sudden death (HP:0001699) | 2.06536712 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.05431283 |
| 64 | Facial diplegia (HP:0001349) | 2.03577510 |
| 65 | Abnormality of the ischium (HP:0003174) | 2.01096828 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.00586369 |
| 67 | Muscle fiber inclusion bodies (HP:0100299) | 10.0196578 |
| 68 | Scapular winging (HP:0003691) | 1.99900481 |
| 69 | Abnormality of the foot musculature (HP:0001436) | 1.99795248 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.97479219 |
| 71 | Gowers sign (HP:0003391) | 1.95896001 |
| 72 | Distal lower limb amyotrophy (HP:0008944) | 1.94607050 |
| 73 | * Asymmetric septal hypertrophy (HP:0001670) | 1.93318383 |
| 74 | Achilles tendon contracture (HP:0001771) | 1.91026586 |
| 75 | Progressive muscle weakness (HP:0003323) | 1.86023729 |
| 76 | Weak cry (HP:0001612) | 1.85895949 |
| 77 | Foot dorsiflexor weakness (HP:0009027) | 1.83696503 |
| 78 | Heart block (HP:0012722) | 1.83298628 |
| 79 | Waddling gait (HP:0002515) | 1.82565486 |
| 80 | Ragged-red muscle fibers (HP:0003200) | 1.79235817 |
| 81 | Tarsal synostosis (HP:0008368) | 1.78652512 |
| 82 | Stridor (HP:0010307) | 1.75474561 |
| 83 | Abnormality of the Achilles tendon (HP:0005109) | 1.74031181 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 1.72496218 |
| 85 | Hyperuricemia (HP:0002149) | 1.72056945 |
| 86 | Increased purine levels (HP:0004368) | 1.72056945 |
| 87 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.67723554 |
| 88 | Increased density of long bones (HP:0006392) | 1.66598204 |
| 89 | Short palpebral fissure (HP:0012745) | 1.66203182 |
| 90 | Popliteal pterygium (HP:0009756) | 1.63945610 |
| 91 | Abnormality of potassium homeostasis (HP:0011042) | 1.63862720 |
| 92 | Cholelithiasis (HP:0001081) | 1.63658568 |
| 93 | Gout (HP:0001997) | 1.62075759 |
| 94 | Ventricular tachycardia (HP:0004756) | 1.61044301 |
| 95 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.60615019 |
| 96 | Synostosis involving bones of the feet (HP:0009140) | 1.60615019 |
| 97 | Fetal akinesia sequence (HP:0001989) | 1.59846600 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.58580585 |
| 99 | Oligomenorrhea (HP:0000876) | 1.55949898 |
| 100 | Adducted thumb (HP:0001181) | 1.53742149 |
| 101 | Ventricular arrhythmia (HP:0004308) | 1.52589709 |
| 102 | Type 2 muscle fiber atrophy (HP:0003554) | 1.52211799 |
| 103 | Hip contracture (HP:0003273) | 1.50862151 |
| 104 | Congenital hip dislocation (HP:0001374) | 1.47269391 |
| 105 | Increased muscle lipid content (HP:0009058) | 1.46941547 |
| 106 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.46845724 |
| 107 | Limited hip movement (HP:0008800) | 1.46782335 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 1.44638821 |
| 109 | Toxemia of pregnancy (HP:0100603) | 1.43476321 |
| 110 | Lower limb amyotrophy (HP:0007210) | 1.43208799 |
| 111 | Muscle fiber atrophy (HP:0100295) | 1.43023706 |
| 112 | Long clavicles (HP:0000890) | 1.41192524 |
| 113 | Exercise intolerance (HP:0003546) | 1.40429438 |
| 114 | Hypokalemia (HP:0002900) | 1.40136285 |
| 115 | Mesomelia (HP:0003027) | 1.38088208 |
| 116 | Lipoatrophy (HP:0100578) | 1.36737741 |
| 117 | Wrist flexion contracture (HP:0001239) | 1.36038022 |
| 118 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.35981067 |
| 119 | Steppage gait (HP:0003376) | 1.27253571 |
| 120 | Amniotic constriction ring (HP:0009775) | 1.22153017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.14085500 |
| 2 | TTN | 6.43135078 |
| 3 | PHKG1 | 5.90535450 |
| 4 | PHKG2 | 5.90535450 |
| 5 | NME1 | 4.73596623 |
| 6 | PIK3CG | 3.69579260 |
| 7 | MAP2K3 | 3.02176806 |
| 8 | NEK1 | 2.36307714 |
| 9 | MAP3K7 | 2.18035042 |
| 10 | PINK1 | 2.06421174 |
| 11 | PDK3 | 1.84772708 |
| 12 | PDK4 | 1.84772708 |
| 13 | TRIB3 | 1.81709855 |
| 14 | MAP2K4 | 1.71568985 |
| 15 | DMPK | 1.68345434 |
| 16 | PIK3CA | 1.66268632 |
| 17 | MAPK12 | 1.65580096 |
| 18 | BCKDK | 1.52911384 |
| 19 | MAP2K6 | 1.49077967 |
| 20 | PDK2 | 1.23819750 |
| 21 | MUSK | 1.07988320 |
| 22 | PRKAA2 | 0.96909527 |
| 23 | NEK9 | 0.93385072 |
| 24 | MAP3K3 | 0.92507736 |
| 25 | MARK1 | 0.91327771 |
| 26 | PRKAA1 | 0.87675927 |
| 27 | TAOK2 | 0.80170759 |
| 28 | MAPKAPK3 | 0.79211940 |
| 29 | ERBB3 | 0.77959483 |
| 30 | TRPM7 | 0.73379142 |
| 31 | MAP3K13 | 0.72295456 |
| 32 | STK24 | 0.66664527 |
| 33 | MAPK11 | 0.61660969 |
| 34 | CAMK4 | 0.60097270 |
| 35 | ZAK | 0.59690712 |
| 36 | MAP3K11 | 0.59313300 |
| 37 | TAOK1 | 0.57106077 |
| 38 | CAMK2G | 0.56771653 |
| 39 | SIK1 | 0.52703333 |
| 40 | AKT2 | 0.52629667 |
| 41 | PKN2 | 0.52423473 |
| 42 | EPHB1 | 0.49814690 |
| 43 | RIPK1 | 0.45659732 |
| 44 | ILK | 0.42290714 |
| 45 | CAMK1 | 0.40707770 |
| 46 | CAMK2B | 0.40269581 |
| 47 | CAMK2A | 0.39541780 |
| 48 | PTK6 | 0.39540177 |
| 49 | LIMK1 | 0.38939637 |
| 50 | EEF2K | 0.35112066 |
| 51 | TBK1 | 0.33958116 |
| 52 | SGK1 | 0.33734929 |
| 53 | MAP3K6 | 0.32885126 |
| 54 | KSR2 | 0.30144635 |
| 55 | PKN1 | 0.27863342 |
| 56 | RPS6KB1 | 0.27123062 |
| 57 | PRKACB | 0.27004203 |
| 58 | MAP3K1 | 0.26901488 |
| 59 | SGK2 | 0.26833770 |
| 60 | PRPF4B | 0.26668702 |
| 61 | MAPK13 | 0.26555940 |
| 62 | PRKG1 | 0.26200610 |
| 63 | MAP3K5 | 0.25381475 |
| 64 | RPS6KA3 | 0.25247136 |
| 65 | ARAF | 0.24108161 |
| 66 | CDK19 | 0.23758065 |
| 67 | CAMK1G | 0.22368432 |
| 68 | RPS6KB2 | 0.22110078 |
| 69 | MAPK7 | 0.20685047 |
| 70 | MAPK4 | 0.20467056 |
| 71 | MAP3K10 | 0.20121594 |
| 72 | PRKACA | 0.18523968 |
| 73 | TYK2 | 0.16290995 |
| 74 | MARK2 | 0.15528326 |
| 75 | PDPK1 | 0.14453251 |
| 76 | RPS6KC1 | 0.14335730 |
| 77 | RPS6KL1 | 0.14335730 |
| 78 | ROCK1 | 0.14277515 |
| 79 | PAK6 | 0.13963260 |
| 80 | DAPK2 | 0.13827533 |
| 81 | INSRR | 0.13652533 |
| 82 | MAP2K1 | 0.12722478 |
| 83 | PRKD1 | 0.12501164 |
| 84 | PNCK | 0.11660874 |
| 85 | PDK1 | 0.11506708 |
| 86 | TIE1 | 0.11340923 |
| 87 | ERN1 | 0.11336043 |
| 88 | LATS2 | 0.11093453 |
| 89 | MOS | 0.10798144 |
| 90 | BRAF | 0.10676903 |
| 91 | BMX | 0.10364749 |
| 92 | MARK3 | 0.10322106 |
| 93 | LATS1 | 0.10196735 |
| 94 | RPS6KA6 | 0.10123933 |
| 95 | RAF1 | 0.10078569 |
| 96 | ZAP70 | 0.09772780 |
| 97 | TGFBR2 | 0.09711505 |
| 98 | SGK223 | 0.09271088 |
| 99 | SGK494 | 0.09271088 |
| 100 | DYRK1B | 0.08651511 |
| 101 | RPS6KA1 | 0.08312795 |
| 102 | LRRK2 | 0.07831681 |
| 103 | PRKACG | 0.05504468 |
| 104 | FGFR1 | 0.05390399 |
| 105 | DDR2 | 0.05243405 |
| 106 | MTOR | 0.04979781 |
| 107 | MAPK10 | 0.04547736 |
| 108 | TNK2 | 0.04348381 |
| 109 | SGK3 | 0.04173451 |
| 110 | STK11 | 0.03488856 |
| 111 | CAMK2D | 0.03482897 |
| 112 | GSK3A | 0.03248324 |
| 113 | ICK | 0.03240171 |
| 114 | JAK2 | 0.03012865 |
| 115 | PTK2B | 0.02450585 |
| 116 | GSK3B | 0.02273961 |
| 117 | MAP3K9 | 0.01972835 |
| 118 | MAPK8 | 0.01940575 |
| 119 | CSNK1D | 0.01563554 |
| 120 | KSR1 | 0.00968976 |
| 121 | MAP3K8 | -0.0274298 |
| 122 | ROCK2 | -0.0263585 |
| 123 | MST1R | -0.0190091 |
| 124 | PRKDC | -0.0146254 |
| 125 | FER | -0.0137609 |
| 126 | MAPK9 | -0.0128469 |
| 127 | CCNB1 | -0.0089883 |
| 128 | RPS6KA2 | -0.0041409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.28656764 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.15472921 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.80812385 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.51067179 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.34986074 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.29820369 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.25571666 |
| 8 | Circadian rhythm_Homo sapiens_hsa04710 | 2.64668108 |
| 9 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.57105746 |
| 10 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.44265312 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34687760 |
| 12 | Insulin resistance_Homo sapiens_hsa04931 | 2.26280086 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.21040246 |
| 14 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.18451728 |
| 15 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.08251864 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97458696 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.92714858 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.91168063 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.85706314 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.77126255 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74023503 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.57425610 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57375153 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.55691240 |
| 25 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55281564 |
| 26 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52456739 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.50864155 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43483884 |
| 29 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.39794664 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38166035 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37667514 |
| 32 | Tight junction_Homo sapiens_hsa04530 | 1.34682391 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30274694 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29711241 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29183195 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27444235 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14270320 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05106348 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.02357543 |
| 40 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.02153534 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.95773867 |
| 42 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94874923 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93519716 |
| 44 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93205587 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87554949 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84652014 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80658186 |
| 48 | * Focal adhesion_Homo sapiens_hsa04510 | 0.80262514 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.77683386 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77046085 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70679686 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 0.70536375 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66208076 |
| 54 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65651270 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56992793 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56707253 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55316632 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.51635653 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50798189 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48750244 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47867842 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.44395883 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43156881 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.41029752 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37413589 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.36955758 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.36639129 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34555786 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33725556 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33478098 |
| 71 | * Gastric acid secretion_Homo sapiens_hsa04971 | 0.32881458 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32827094 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32162189 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31698757 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30334954 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.30308604 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29446407 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.29141125 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28575588 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26831054 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24222479 |
| 82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24049558 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22312095 |
| 84 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21215601 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21210564 |
| 86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19257102 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18356605 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16619953 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14947650 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14629779 |
| 91 | * Platelet activation_Homo sapiens_hsa04611 | 0.14620969 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.14481491 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.14171748 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.13813884 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13399575 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13244999 |
| 97 | Long-term potentiation_Homo sapiens_hsa04720 | 0.12163334 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12130010 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.10976123 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.10433496 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.10305249 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.10269425 |
| 103 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09803073 |
| 104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.08330799 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.08330411 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.08320484 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.08178554 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.07779544 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.07416578 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.07346287 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07076368 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07070850 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05948949 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03909868 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.03858383 |
| 116 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.03389200 |
| 117 | ABC transporters_Homo sapiens_hsa02010 | 0.02742607 |

